Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model

British Journal of Nutrition

Volumn 102, Issue 10, 2009, Pages 1420-1425

  Girard, Stphanie Anne ^a,b   Bah, Thierno Madjou ^a   Kaloustian, Svan ^a,b   Lada Moldovan, Laura ^a,b   Rondeau, Isabelle ^a,b   Tompkins, Thomas A ^c   Godbout, Roger ^a,b   Rousseau, Guy ^a,b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LALLEMAND SAS   (France)

Author keywords

Apoptosis; Limbic system; Myocardial infarction; Probiotics

Indexed keywords

CASPASE 3; DRINKING WATER; PLACEBO; PROBIO STICK; PROBIOTIC AGENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIFIDOBACTERIUM LONGUM; BRAIN REGION; CONTROLLED STUDY; CORONARY REPERFUSION; DENTATE GYRUS; DEPRESSION; DISEASE MODEL; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; LACTOBACILLUS HELVETICUS; LEFT CORONARY ARTERY; LIMBIC SYSTEM; MALE; NONHUMAN; RAT; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIFIDOBACTERIUM; CASPASE 3; DIET; ENZYME ACTIVATION; LACTOBACILLUS HELVETICUS; LIMBIC SYSTEM; MALE; MYOCARDIAL INFARCTION; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PROBIOTICS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY;

BIFIDOBACTERIUM LONGUM; LACTOBACILLUS HELVETICUS; RATTUS;

EID: 73649211083     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509990766     Document Type: Article

References (40)

1. Francis J, Chu Y, Johnson AK, et al. (2004) Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol 286, H2264-H2271.
2. Francis J, Zhang Z-H, Weiss RM, et al. (2004) Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am J Physiol 287, H791-H797. (Pubitemid 38955314)
3. Wann BP, Bah TM, Kaloustian S, et al. (2009) Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline. J Psychopharmacol 23, 451-459.
4. Wann BP, Boucher M, Kaloustian S, et al. (2006) Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol Psychiatry 59, 430-433.
5. Wann BP, Bah TM, Boucher M, et al. (2007) Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. J Psychiatry Neurosci 32, 11-16.
6. Frasure-Smith N, Lesperance F & Talajic M (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA 270, 1819-1825.
7. Lesperance F, Frasure-Smith N, Talajic M, et al. (2002) Fiveyear risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105, 1049-1053.
8. Mawdsley JE & Rampton DS (2005) Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54, 1481-1491.
9. Monnikes H, Tebbe JJ, Hildebrandt M, et al. (2001) Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 19, 201-211.
10. Gareau MG, Silva MA & Perdue MH (2008) Pathophysiological mechanisms of stress-induced intestinal damage. Curr Mol Med 8, 274-281.
11. Maes M, Kubera M & Leunis JC (2008) The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29, 117-124.
12. Lammers KM, Brigidi P, Vitali B, et al. (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38, 165-172.
13. Yan F & Polk DB (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277, 50959-50965.
14. Diop L, Guillou S & Durand H (2008) Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial. Nutr Res 28, 1-5.
15. Sherman PM, Johnson-Henry KC, Yeung HP, et al. (2005) Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 73, 5183-5188.
16. Gareau MG, Jury J, MacQueen G, et al. (2007) Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 56, 1522-1528.
17. Wallace TD, Bradley S, Buckley ND, et al. (2003) Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot 66, 466-472.
18. Haskey N & Dahl WJ (2009) Synbiotic therapy improves quality of life and reduces symptoms in pediatric ulcerative colitis. Infant Child Adoles Nutr 1, 88-93.
19. Paxinos G & Watson C (1986) The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
20. Varghese AK, Verdu EF, Bercik P, et al. (2006) Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 130, 1743-1753.
21. Banks WA (2006) The blood-brain barrier as a regulatory interface in the gut-brain axes. Physiol Behav 89, 472-476.
22. Verdu EF, Bercik P, Huang XX, et al. (2008) The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol 295, G664-G670.
23. Ng SC, Hart AL, Kamm MA, et al. (2009) Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 15, 300-310.
24. Bai AP, Ouyang Q, Xiao XR, et al. (2006) Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int J Clin Pract 60, 284-288.
25. Boucher M, Wann BP, Kaloustian S, et al. (2006) Reduction of apoptosis in the amygdala by an A2A adenosine receptor agonist following myocardial infarction. Apoptosis 11, 1067-1074.
26. Adams JM (2003) Ways of dying: multiple pathways to apoptosis. Genes Dev 17, 2481-2495.
27. Sugawara T, Fujimura M, Noshita N, et al. (2004) Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 1, 17-25.
28. Reyland ME (2007) Protein kinase C and apoptosis. Apoptosis, Cell Signaling, and Human Diseases, pp. 31-55 [R Srivastava, editor]. Totowa, NJ: Humana Press.
29. Datta K, Bellacosa A, Chan TO, et al. (1996) Akt is a direct target of the phosphatidylinositol 3-kinase. J Biol Chem 271, 30835-30839.
30. Datta SR, Dudek H, Tao X, et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241.
31. Lawlor MA & Alessi DR (2001) PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114, 2903-2910.
32. Morley S, Wagner J, Kauppinen K, et al. (2007) Requirement for Akt-mediated survival in cell transformation by the dbl oncogene. Cell Signal 19, 211-218.
33. Yan F, Cao H, Cover TL, et al. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575.
34. de Lorgeril M, Rousseau G, Basmadjian A, et al. (1990) Spacial and temporal profiles of neutrophil accumulation in the reperfused ischemic myocardium. Am J Cardiovasc Pathol 3, 143-154.
35. Vinten-Johansen J (2004) Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61, 481-497.
36. Gu Q, Yang XP, Bonde P, et al. (2006) Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog. J Cardiovasc Pharmacol 48, 320-328.
37. Maekawa N, Wada H, Kanda T, et al. (2002) Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol 39, 1229-1235.
38. Deuchar GA, Opie LH & Lecour S (2007) TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning. Life Sci 80, 1686-1691.
39. Dawn B, Guo Y, Rezazadeh A, et al. (2004) Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 37, 51-61.
40. McVey M, Perrone MH & Clark KL (1999) Does tumor necrosis factor-alpha (TNF-alpha) contribute to myocardial reperfusion injury in anesthetized rats? Gen Pharmacol 32, 41-45. (Pubitemid 28540788)